1-5 of 5
Patricia Yotnda
Close
Sort by
Journal Articles

Conditional T-Cell Activation for Tumor Under Hypoxia

Sonny O Ang, PhD, Simon Olivares, BS, Elizabeth J. Shpall, MD, Dean A. Lee, MD, PhD, Richard Champlin, Patricia Yotnda, PhD, Stephen Gottschalk, MD, Laurence Cooper, MD, PhD
Journal: Blood
Blood (2008) 112 (11): 3906.
https://doi.org/10.1182/blood.V112.11.3906.3906
Published: 2008
Journal Articles

An inducible caspase 9 safety switch for T-cell therapy

Karin C. Straathof, Martin A. Pulè, Patricia Yotnda, Gianpietro Dotti, Elio F. Vanin, Malcolm K. Brenner, Helen E. Heslop, David M. Spencer, Cliona M. Rooney
Journal: Blood
Blood (2005) 105 (11): 4247–4254.
https://doi.org/10.1182/blood-2004-11-4564
Published: 2005
Includes: Supplemental data
Journal Articles

Inducible Caspase 9 as a Safety Switch in Genetically Modified Cytotoxic T Cells.

Karin C. Straathof, MD, Martin A. Pule, MD, Patricia Yotnda, PhD, Gianpietro Dotti, MD, Elio F. Vanin, PhD, Malcolm K. Brenner, MD, PhD, Helen E. Heslop, MD, PhD, David M. Spencer, PhD, Cliona M. Rooney, PhD
Journal: Blood
Blood (2004) 104 (11): 1743.
https://doi.org/10.1182/blood.V104.11.1743.1743
Published: 2004
Journal Articles

Targeted delivery of adenoviral vectors by cytotoxic T cells

Patricia Yotnda, Barbara Savoldo, Nicolas Charlet-Berguerand, Cliona Rooney, Malcolm Brenner
Journal: Blood
Blood (2004) 104 (8): 2272–2280.
https://doi.org/10.1182/blood-2003-11-3803
Published: 2004
Journal Articles

Transgenic expression of CD40 ligand produces an in vivo antitumor immune response against both CD40 + and CD40 − plasmacytoma cells

Gianpietro Dotti, Barbara Savoldo, Patricia Yotnda, Donna Rill, Malcolm K. Brenner
Journal: Blood
Blood (2002) 100 (1): 200–207.
https://doi.org/10.1182/blood.V100.1.200
Published: 2002